2013
DOI: 10.1021/bm401677n
|View full text |Cite
|
Sign up to set email alerts
|

Stimuli-Induced Release of Compounds from Elastin Biomimetic Matrix

Abstract: Stimuli-responsive hydrogel matrices have attracted great attention in biomedical and biotechnological fields for controlled delivery of bioactive compounds, as well as a vehicle for therapeutic cell spreading. Elastin-derived biomimetic polypeptides are recombinant macromolecules suitable for the realization of smart biomaterials. In this study, we explored the potential of an elastin biomimetic matrix to realize proteolytic stimuli-responsive systems to control the release of substances. Our approach showed … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
31
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
7
1
1

Relationship

3
6

Authors

Journals

citations
Cited by 26 publications
(32 citation statements)
references
References 45 publications
1
31
0
Order By: Relevance
“…The enzymatic degradation of ELP assemblies for drug release can be preferentially targeted to regions with increased elastase activity, which often correlate with pathological conditions such as pulmonary emphysema, cystic fibrosis, bacterial infections, inflammation, chronic wounds and atherosclerosis . In support, a stable ELP hydrogel demonstrated enhanced drug release when exposed to elastolytic activity from Pseudomonas aeruginosa and from activated human polymorphonuclear leukocytes …”
Section: Elastin‐like Peptide (Elp) Constructsmentioning
confidence: 98%
“…The enzymatic degradation of ELP assemblies for drug release can be preferentially targeted to regions with increased elastase activity, which often correlate with pathological conditions such as pulmonary emphysema, cystic fibrosis, bacterial infections, inflammation, chronic wounds and atherosclerosis . In support, a stable ELP hydrogel demonstrated enhanced drug release when exposed to elastolytic activity from Pseudomonas aeruginosa and from activated human polymorphonuclear leukocytes …”
Section: Elastin‐like Peptide (Elp) Constructsmentioning
confidence: 98%
“…For example, Bandiera et al engineered proteolytically-responsive scaffolds for delivery of model proteins using elastin-derived biomimetic peptides of recombinant origin. 36 Incorporation of Controlled-release Technology: Growth factors and other compounds such as antibiotics 37 have been incorporated into scaffold/matrix designs for a variety of purposes. For example, controlled release systems can entail bulk incorporation of growth factors into the scaffold matrix by adsorption or chemical coupling, 38 incorporation of delivery drug-laden vehicles/carriers, such as microspheres, into the scaffold matrix, 39 or surface functionalization of the ECM proteins with moieties that have high growth factor binding affinities, for example heparin sulfates in the case of VEGFs and FGFs.…”
Section: Ecm-inspired Smart Matrix Designmentioning
confidence: 99%
“…In this sense, Bandiera [73] has described the behavior of different cell lines cultured on surfaces coated with an ELR that adopts a defined pattern of concentric circles. The good adhesiveness displayed by all the cell lines studied is noteworthy, with the specific behavior depending on the cell type concerned.…”
Section: Modification Of Surface Topography By Elrsmentioning
confidence: 99%